IBDEI11W ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16890,1,4,0)
 ;;=4^K76.0
 ;;^UTILITY(U,$J,358.3,16890,2)
 ;;=^5008831
 ;;^UTILITY(U,$J,358.3,16891,0)
 ;;=K76.89^^88^882^18
 ;;^UTILITY(U,$J,358.3,16891,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16891,1,3,0)
 ;;=3^Liver Disease NEC
 ;;^UTILITY(U,$J,358.3,16891,1,4,0)
 ;;=4^K76.89
 ;;^UTILITY(U,$J,358.3,16891,2)
 ;;=^5008835
 ;;^UTILITY(U,$J,358.3,16892,0)
 ;;=K71.6^^88^882^32
 ;;^UTILITY(U,$J,358.3,16892,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16892,1,3,0)
 ;;=3^Toxic Liver Disease w/ Hepatitis NEC
 ;;^UTILITY(U,$J,358.3,16892,1,4,0)
 ;;=4^K71.6
 ;;^UTILITY(U,$J,358.3,16892,2)
 ;;=^5008801
 ;;^UTILITY(U,$J,358.3,16893,0)
 ;;=K75.9^^88^882^17
 ;;^UTILITY(U,$J,358.3,16893,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16893,1,3,0)
 ;;=3^Inflammatory Liver Disease,Unspec
 ;;^UTILITY(U,$J,358.3,16893,1,4,0)
 ;;=4^K75.9
 ;;^UTILITY(U,$J,358.3,16893,2)
 ;;=^5008830
 ;;^UTILITY(U,$J,358.3,16894,0)
 ;;=K71.0^^88^882^24
 ;;^UTILITY(U,$J,358.3,16894,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16894,1,3,0)
 ;;=3^Toxic Liver Disease w/ Cholestasis
 ;;^UTILITY(U,$J,358.3,16894,1,4,0)
 ;;=4^K71.0
 ;;^UTILITY(U,$J,358.3,16894,2)
 ;;=^5008793
 ;;^UTILITY(U,$J,358.3,16895,0)
 ;;=K71.10^^88^882^30
 ;;^UTILITY(U,$J,358.3,16895,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16895,1,3,0)
 ;;=3^Toxic Liver Disease w/ Hepatic Necrosis w/o Coma
 ;;^UTILITY(U,$J,358.3,16895,1,4,0)
 ;;=4^K71.10
 ;;^UTILITY(U,$J,358.3,16895,2)
 ;;=^5008794
 ;;^UTILITY(U,$J,358.3,16896,0)
 ;;=K71.11^^88^882^31
 ;;^UTILITY(U,$J,358.3,16896,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16896,1,3,0)
 ;;=3^Toxic Liver Disease w/ Hepatic Necrosis w/ Coma
 ;;^UTILITY(U,$J,358.3,16896,1,4,0)
 ;;=4^K71.11
 ;;^UTILITY(U,$J,358.3,16896,2)
 ;;=^5008795
 ;;^UTILITY(U,$J,358.3,16897,0)
 ;;=K71.2^^88^882^23
 ;;^UTILITY(U,$J,358.3,16897,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16897,1,3,0)
 ;;=3^Toxic Liver Disease w/ Acute Hepatitis
 ;;^UTILITY(U,$J,358.3,16897,1,4,0)
 ;;=4^K71.2
 ;;^UTILITY(U,$J,358.3,16897,2)
 ;;=^5008796
 ;;^UTILITY(U,$J,358.3,16898,0)
 ;;=K71.3^^88^882^28
 ;;^UTILITY(U,$J,358.3,16898,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16898,1,3,0)
 ;;=3^Toxic Liver Disease w/ Chronic Persistent Hepatitis
 ;;^UTILITY(U,$J,358.3,16898,1,4,0)
 ;;=4^K71.3
 ;;^UTILITY(U,$J,358.3,16898,2)
 ;;=^5008797
 ;;^UTILITY(U,$J,358.3,16899,0)
 ;;=K71.4^^88^882^27
 ;;^UTILITY(U,$J,358.3,16899,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16899,1,3,0)
 ;;=3^Toxic Liver Disease w/ Chronic Lobular Hepatitis
 ;;^UTILITY(U,$J,358.3,16899,1,4,0)
 ;;=4^K71.4
 ;;^UTILITY(U,$J,358.3,16899,2)
 ;;=^5008798
 ;;^UTILITY(U,$J,358.3,16900,0)
 ;;=K75.81^^88^882^19
 ;;^UTILITY(U,$J,358.3,16900,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16900,1,3,0)
 ;;=3^Nonalcoholic Steatohepatitis (NASH)
 ;;^UTILITY(U,$J,358.3,16900,1,4,0)
 ;;=4^K75.81
 ;;^UTILITY(U,$J,358.3,16900,2)
 ;;=^5008828
 ;;^UTILITY(U,$J,358.3,16901,0)
 ;;=K75.89^^88^882^16
 ;;^UTILITY(U,$J,358.3,16901,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16901,1,3,0)
 ;;=3^Inflammatory Liver Disease,Oth Spec
 ;;^UTILITY(U,$J,358.3,16901,1,4,0)
 ;;=4^K75.89
 ;;^UTILITY(U,$J,358.3,16901,2)
 ;;=^5008829
 ;;^UTILITY(U,$J,358.3,16902,0)
 ;;=K76.4^^88^882^21
 ;;^UTILITY(U,$J,358.3,16902,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16902,1,3,0)
 ;;=3^Peliosis Hepatis
 ;;^UTILITY(U,$J,358.3,16902,1,4,0)
 ;;=4^K76.4
